Close Menu

NEW YORK (GenomeWeb) — Australian molecular diagnostics firm Genetic Technologies said today that it has received a notice from the Nasdaq Stock Market that it is no longer in compliance with the stock exchange's listing requirements.

According to Genetic Technologies, the Nasdaq said that the company's reported shareholders' equity is less than the required minimum of $2.5 million as of the end of 2018, and that it does not meet the alternatives of market value of listed securities or net income from continuing operations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.